Literature DB >> 36184635

MR imaging profile and histopathological characteristics of tumour vasculature, cell density and proliferation rate define two distinct growth patterns of human brain metastases from lung cancer.

Makoto Kiyose1,2,3,4, Eva Herrmann5, Jenny Roesler6, Pia S Zeiner2,3,4,7,8,9, Joachim P Steinbach3,4,7,8,9, Marie-Therese Forster10, Karl H Plate6,8,9, Marcus Czabanka10, Thomas J Vogl11, Elke Hattingen1, Michel Mittelbronn6,12,13,14,15,16,17, Stella Breuer1, Patrick N Harter6,8,9, Simon Bernatz18,19,20,21.   

Abstract

PURPOSE: Non-invasive prediction of the tumour of origin giving rise to brain metastases (BMs) using MRI measurements obtained in radiological routine and elucidating the biological basis by matched histopathological analysis.
METHODS: Preoperative MRI and histological parameters of 95 BM patients (female, 50; mean age 59.6 ± 11.5 years) suffering from different primary tumours were retrospectively analysed. MR features were assessed by region of interest (ROI) measurements of signal intensities on unenhanced T1-, T2-, diffusion-weighted imaging and apparent diffusion coefficient (ADC) normalised to an internal reference ROI. Furthermore, we assessed BM size and oedema as well as cell density, proliferation rate, microvessel density and vessel area as histopathological parameters.
RESULTS: Applying recursive partitioning conditional inference trees, only histopathological parameters could stratify the primary tumour entities. We identified two distinct BM growth patterns depending on their proliferative status: Ki67high BMs were larger (p = 0.02), showed less peritumoural oedema (p = 0.02) and showed a trend towards higher cell density (p = 0.05). Furthermore, Ki67high BMs were associated with higher DWI signals (p = 0.03) and reduced ADC values (p = 0.004). Vessel density was strongly reduced in Ki67high BM (p < 0.001). These features differentiated between lung cancer BM entities (p ≤ 0.03 for all features) with SCLCs representing predominantly the Ki67high group, while NSCLCs rather matching with Ki67low features.
CONCLUSION: Interpretable and easy to obtain MRI features may not be sufficient to predict directly the primary tumour entity of BM but seem to have the potential to aid differentiating high- and low-proliferative BMs, such as SCLC and NSCLC.
© 2022. The Author(s).

Entities:  

Keywords:  Brain metastasis; Histopathology; Imaging biomarker; Magnetic resonance imaging; Tumour vasculature

Year:  2022        PMID: 36184635     DOI: 10.1007/s00234-022-03060-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.995


  25 in total

Review 1.  Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.

Authors:  J Faehndrich; S Weidauer; U Pilatus; A Oszvald; F E Zanella; E Hattingen
Journal:  Clin Neuroradiol       Date:  2011-05-03       Impact factor: 3.649

2.  Characterization of brain tumors by MRS, DWI and Ki-67 labeling index.

Authors:  J A Calvar; F J Meli; C Romero; M L Calcagno; P Yánez; A R Martinez; H Lambre; A L Taratuto; G Sevlever
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

3.  Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.

Authors:  Faith G Davis; Therese A Dolecek; Bridget J McCarthy; John L Villano
Journal:  Neuro Oncol       Date:  2012-08-16       Impact factor: 12.300

4.  Metastatic adenocarcinoma in the brain: magnetic resonance imaging with pathological correlations to mucin content.

Authors:  Shinya Oshiro; Hitoshi Tsugu; Fuminari Komatsu; Hiroshi Abe; Tadahiro Ohmura; Seisaburou Sakamoto; Takeo Fukushima
Journal:  Anticancer Res       Date:  2008 Jan-Feb       Impact factor: 2.480

5.  Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.

Authors:  Thomas Spanberger; Anna S Berghoff; Carina Dinhof; Aysegül Ilhan-Mutlu; Manuel Magerle; Markus Hutterer; Josef Pichler; Adelheid Wöhrer; Monika Hackl; Georg Widhalm; Johannes A Hainfellner; Karin Dieckmann; Christine Marosi; Peter Birner; Daniela Prayer; Matthias Preusser
Journal:  Clin Exp Metastasis       Date:  2012-10-17       Impact factor: 5.150

6.  MRI T2 hypointensity of metastatic brain tumors from gastric and colonic cancers.

Authors:  Hirofumi Hirano; Shunichi Yokoyama; Shunji Yunoue; Hajime Yonezawa; Kazutaka Yatsushiro; Takako Yoshioka; Ryosuke Hanaya; Hiroshi Tokimura; Kazunori Arita
Journal:  Int J Clin Oncol       Date:  2013-07-17       Impact factor: 3.402

7.  Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics.

Authors:  Alexander C Guo; Thomas J Cummings; Rajesh C Dash; James M Provenzale
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

8.  Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.

Authors:  H R Arvinda; C Kesavadas; P S Sarma; B Thomas; V V Radhakrishnan; A K Gupta; T R Kapilamoorthy; S Nair
Journal:  J Neurooncol       Date:  2009-02-20       Impact factor: 4.130

Review 9.  Intracranial metastases: spectrum of MR imaging findings.

Authors:  Eun Kyoung Lee; Eun Ja Lee; Mi Sung Kim; Hee-Jin Park; No Hyuck Park; Sung Park; Yong Seok Lee
Journal:  Acta Radiol       Date:  2012-10-18       Impact factor: 1.990

10.  Diffusion-Weighted Imaging in Meningioma: Prediction of Tumor Grade and Association with Histopathological Parameters.

Authors:  Alexey Surov; Sebastian Gottschling; Christian Mawrin; Julian Prell; Rolf Peter Spielmann; Andreas Wienke; Eckhard Fiedler
Journal:  Transl Oncol       Date:  2015-12       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.